Farnesol, at 0.06 × 104 ppm concentration was tested against the fifth nymphal instar of Locusta migratoria induced antifeedant activity by 33.6 % and 45 % to males and females, respectively. Ultrastructural studies, using transmission electron microscopy, revealed marked pathological changes in the neurosecretory cells in brain and corpora allata (CA) cells of treated nymphs. The brain neurosecretion was held inside the neurosecretory cells whose axons did not liberate normally, leading to the accumulation of neurosecretory granules inside. These cells appeared ruptured and irregular. Corpora allata cells had hypertrophied nuclei, numerous lysosomes, malformed mitochondria, Golgi bodies and some other intracellular organelles in the gland cells. Multivesicular bodies were scattered and intercellular spaces appeared within the cell matrix. The haemolymph testosterone and progesterone levels were significantly decreased in the fifth nymphal instar treated with farnesol. Moreover, haemolymph and brain superoxide dismutase (SOD) activity were significantly decreased in brains of treated males and females. On the other hand, haemolymph malondialdehyde (MAD) only declined. By contrast, the brain MDA level was significantly increased in farnesol-treated fifth nymphal instars of both sexes. The ultrastructural and biochemical changes reflect the sensitivity of L. migratoria to farnesol as a neurotoxin bioinsecticide. It appears that the changes in the biochemical macromolecules reflect the ultrastructural alterations obtained. Thus, farnesol can be used as a promising biocide against the migratory locusts as it could be mixed in bait traps in the integrated pest management programme (IPM).
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 24 • No. 2